BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11602031)

  • 1. Analysis of neurosteroid levels in attention deficit hyperactivity disorder.
    Strous RD; Spivak B; Yoran-Hegesh R; Maayan R; Averbuch E; Kotler M; Mester R; Weizman A
    Int J Neuropsychopharmacol; 2001 Sep; 4(3):259-64. PubMed ID: 11602031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder.
    Maayan R; Yoran-Hegesh R; Strous R; Nechmad A; Averbuch E; Weizman A; Spivak B
    Neuropsychobiology; 2003; 48(3):111-5. PubMed ID: 14586159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in susceptibility to schizophrenia: Potential implication of neurosteroids.
    Huang YC; Hung CF; Lin PY; Lee Y; Wu CC; Hsu ST; Chen CC; Chong MY; Lin CH; Wang LJ
    Psychoneuroendocrinology; 2017 Oct; 84():87-93. PubMed ID: 28686904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP; Kirkpatrick PJ; Goodyer IM; Shiers HM; Herbert J
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate.
    Wang LJ; Hsiao CC; Huang YS; Chiang YL; Ree SC; Chen YC; Wu YW; Wu CC; Shang ZY; Chen CK
    Psychoneuroendocrinology; 2011 Sep; 36(8):1209-16. PubMed ID: 21411231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone sulfate, free testosterone, and sex hormone-binding globulin on susceptibility to attention-deficit/hyperactivity disorder.
    Wang LJ; Lee SY; Chou MC; Lee MJ; Chou WJ
    Psychoneuroendocrinology; 2019 May; 103():212-218. PubMed ID: 30711898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced plasma dehydroepiandrosterone sulfate levels are significantly correlated with fatigue severity in patients with primary biliary cirrhosis.
    Ahboucha S; Pomier-Layrargues G; Vincent C; Hassoun Z; Tamaz R; Baker G; Butterworth RF
    Neurochem Int; 2008; 52(4-5):569-74. PubMed ID: 17669554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.
    Iancu I; Tchernihovsky E; Maayan R; Poreh A; Dannon P; Kotler M; Weizman A; Strous RD
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):541-5. PubMed ID: 17346944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.
    Strous RD; Maayan R; Lapidus R; Goredetsky L; Zeldich E; Kotler M; Weizman A
    Schizophr Res; 2004 Dec; 71(2-3):427-34. PubMed ID: 15474914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder.
    Spivak B; Vered Y; Yoran-Hegesh R; Averbuch E; Mester R; Graf E; Weizman A
    Acta Psychiatr Scand; 1999 Apr; 99(4):300-4. PubMed ID: 10223434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder.
    Işık Ü; Bilgiç A; Toker A; Kılınç I
    Psychiatry Res; 2018 Mar; 261():212-219. PubMed ID: 29324397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation.
    Wang LJ; Chan WC; Chou MC; Chou WJ; Lee MJ; Lee SY; Lin PY; Yang YH; Yen CF
    Sci Rep; 2017 Apr; 7():45595. PubMed ID: 28367959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary neurosteroid levels and behavioural profiles of children with attention-deficit/hyperactivity disorder during six months of methylphenidate treatment.
    Wang LJ; Wu CC; Lee SY; Tsai YF
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):336-40. PubMed ID: 24956271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia.
    Laufer N; Maayan R; Hermesh H; Marom S; Gilad R; Strous R; Weizman A
    Psychiatry Res; 2005 Nov; 137(1-2):131-6. PubMed ID: 16226317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum DHEA-S concentration correlates with clinical symptoms and neurocognitive function in patients with bipolar II disorder: A case-controlled study.
    Lee SY; Wang LJ; Chang CH; Wu CC; Chen HL; Lin SH; Chu CL; Lu T; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():31-35. PubMed ID: 27914864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowered DHEA-S plasma levels in adult individuals with autistic disorder.
    Strous RD; Golubchik P; Maayan R; Mozes T; Tuati-Werner D; Weizman A; Spivak B
    Eur Neuropsychopharmacol; 2005 May; 15(3):305-9. PubMed ID: 15820420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploratory pilot investigation of neurosteroids and self-reported pain in female Iraq/Afghanistan-era Veterans.
    Naylor JC; Kilts JD; Strauss JL; Szabo ST; Dunn CE; Wagner HR; Hamer RM; Shampine LJ; Zanga JR; Marx CE;
    J Rehabil Res Dev; 2016; 53(4):499-510. PubMed ID: 27533747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum allopregnanolone levels in children with attention deficit hyperactivity disorder.
    Şahin İ; Say GN; Avcı B; Kesim N
    Psychoneuroendocrinology; 2022 Dec; 146():105923. PubMed ID: 36152454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.
    Ritsner M; Maayan R; Gibel A; Weizman A
    Eur Neuropsychopharmacol; 2007 Apr; 17(5):358-65. PubMed ID: 17123790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.